Webdisclosure.com

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

14/01/2022 07:00

EQS-Adhoc: Relief Therapeutics Comments on NRx Pharmaceuticals' Press Release Reporting on its Recently Filed Lawsuit

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

12/01/2022 07:00

EQS-Adhoc: Relief Comments on Lawsuit Filed Against It by NeuroRx

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

06/01/2022 07:20

Relief Reports US Collab. Partner Announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

06/01/2022 07:00

EQS-Adhoc: Relief Reports US Collab. Partner announces Submission to FDA seeking EUA for Aviptadil for Pts at Immediate Risk of Death from COVID-19 Despite Treatment w/Remdesivir, Other Approved Therapies

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

05/01/2022 07:20

Relief Therapeutics to Participate in Virtual Investor Conferences in January

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

05/01/2022 07:00

EQS-News: Relief Therapeutics to Participate in Virtual Investor Conferences in January

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

04/01/2022 07:30

Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions of Aviptadil Suitable for Human Use

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

04/01/2022 07:00

EQS-Adhoc: Relief Reports that its U.S. Collaboration Partner has Announced the Filing of a Provisional Patent Application for Stable Compositions of Aviptadil Suitable for Human Use

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

03/01/2022 07:25

Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA

Voir tous les communiqués de Relief Therapeutics Holdings AG

RELIEF THERAPEUTICS HOLDINGS AG (NASDAQ:RLFTF)

03/01/2022 07:00

EQS-Adhoc: Relief Therapeutics Announces Notice of Extraordinary General Meeting of RELIEF THERAPEUTICS Holding SA

Voir tous les communiqués de Relief Therapeutics Holdings AG

«
5
6
7
8
9
10
11
12
13
14
15